Clinical Trial Update: Pharmacogenomics of Asparaginase Induced Hepatotoxicity

View source ↗

Summary

A clinical trial update describes ongoing pharmacogenomic research into factors that influence asparaginase-induced hepatotoxicity in acute lymphoblastic leukem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Asparaginase (asparaginase)

Snippet

Sponsor: University of Southern California | Conditions: Acute Lymphoblastic Leukemia | Status: RECRUITING